These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 22576324

  • 1. Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers.
    Hulskotte E, Gupta S, Xuan F, van Zutven M, O'Mara E, Feng HP, Wagner J, Butterton J.
    Hepatology; 2012 Nov; 56(5):1622-30. PubMed ID: 22576324
    [Abstract] [Full Text] [Related]

  • 2. Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus.
    Garg V, van Heeswijk R, Lee JE, Alves K, Nadkarni P, Luo X.
    Hepatology; 2011 Jul; 54(1):20-7. PubMed ID: 21618566
    [Abstract] [Full Text] [Related]

  • 3. Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents--a potentially lethal cocktail.
    Charlton M.
    Hepatology; 2011 Jul; 54(1):3-5. PubMed ID: 21710471
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacokinetic interactions between the hepatitis C virus protease inhibitor boceprevir and ritonavir-boosted HIV-1 protease inhibitors atazanavir, darunavir, and lopinavir.
    Hulskotte EG, Feng HP, Xuan F, van Zutven MG, Treitel MA, Hughes EA, O'Mara E, Youngberg SP, Wagner JA, Butterton JR.
    Clin Infect Dis; 2013 Mar; 56(5):718-26. PubMed ID: 23155151
    [Abstract] [Full Text] [Related]

  • 5. Effect of oral posaconazole on the pharmacokinetics of cyclosporine and tacrolimus.
    Sansone-Parsons A, Krishna G, Martinho M, Kantesaria B, Gelone S, Mant TG.
    Pharmacotherapy; 2007 Jun; 27(6):825-34. PubMed ID: 17542765
    [Abstract] [Full Text] [Related]

  • 6. Lack of a clinically significant drug-drug interaction in healthy volunteers between the HCV protease inhibitor boceprevir and the proton pump inhibitor omeprazole.
    de Kanter CT, Colbers AP, Blonk MI, Verweij-van Wissen CP, Schouwenberg BJ, Drenth JP, Burger DM.
    J Antimicrob Chemother; 2013 Jun; 68(6):1415-22. PubMed ID: 23429642
    [Abstract] [Full Text] [Related]

  • 7. An open-label investigation into drug-drug interactions between multiple doses of daclatasvir and single-dose cyclosporine or tacrolimus in healthy subjects.
    Bifano M, Adamczyk R, Hwang C, Kandoussi H, Marion A, Bertz RJ.
    Clin Drug Investig; 2015 May; 35(5):281-9. PubMed ID: 25896946
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic interaction between HCV protease inhibitor boceprevir and methadone or buprenorphine in subjects on stable maintenance therapy.
    Hulskotte EG, Bruce RD, Feng HP, Webster LR, Xuan F, Lin WH, O'Mara E, Wagner JA, Butterton JR.
    Eur J Clin Pharmacol; 2015 Mar; 71(3):303-11. PubMed ID: 25666027
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetic evaluation of the interaction between hepatitis C virus protease inhibitor boceprevir and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors atorvastatin and pravastatin.
    Hulskotte EG, Feng HP, Xuan F, Gupta S, van Zutven MG, O'Mara E, Wagner JA, Butterton JR.
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2582-8. PubMed ID: 23529734
    [Abstract] [Full Text] [Related]

  • 10. Oseltamivir, an influenza neuraminidase inhibitor drug, does not affect the steady-state pharmacokinetic characteristics of cyclosporine, mycophenolate, or tacrolimus in adult renal transplant patients.
    Lam H, Jeffery J, Sitar DS, Aoki FY.
    Ther Drug Monit; 2011 Dec; 33(6):699-704. PubMed ID: 22105586
    [Abstract] [Full Text] [Related]

  • 11. Single-dose pharmacokinetics of boceprevir in subjects with impaired hepatic or renal function.
    Treitel M, Marbury T, Preston RA, Triantafyllou I, Feely W, O'Mara E, Kasserra C, Gupta S, Hughes EA.
    Clin Pharmacokinet; 2012 Sep 01; 51(9):619-28. PubMed ID: 22799589
    [Abstract] [Full Text] [Related]

  • 12. [Experience in the management of immunosuppressant treatment with hepatitis C virus protease inhibitors].
    Ruiz Ramos J, Romero Hernández I, Marrero Álvarez P, Marqués Miñana MR, Fernández Megía MJ, Poveda Andrés JL.
    Gastroenterol Hepatol; 2014 Dec 01; 37(10):558-63. PubMed ID: 24951300
    [Abstract] [Full Text] [Related]

  • 13. Lack of a clinically significant drug-drug interaction in healthy volunteers between the hepatitis C virus protease inhibitor boceprevir and the HIV integrase inhibitor raltegravir.
    de Kanter CT, Blonk MI, Colbers AP, Schouwenberg BJ, Burger DM.
    Clin Infect Dis; 2013 Jan 01; 56(2):300-6. PubMed ID: 23001704
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of the co-administration of boceprevir and St John's wort to male and female healthy volunteers.
    Jackson A, D'Avolio A, Moyle G, Bonora S, Di Perri G, Else L, Simiele M, Singh GJ, Back D, Boffito M.
    J Antimicrob Chemother; 2014 Jul 01; 69(7):1911-5. PubMed ID: 24610312
    [Abstract] [Full Text] [Related]

  • 15. A Phase I study to assess the safety, tolerability and pharmacokinetic profile of boceprevir and sildenafil when dosed separately and together, in healthy male volunteers.
    Mora-Peris B, Else L, Goldmeier D, Mears A, Weston R, Cooke G, Khoo S, Back D, Winston A.
    J Antimicrob Chemother; 2015 Jul 01; 70(6):1812-5. PubMed ID: 25693997
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetic Interactions Between Elbasvir/Grazoprevir and Immunosuppressant Drugs in Healthy Volunteers.
    Feng HP, Caro L, Fandozzi CM, Guo Z, Talaty J, Wolford D, Panebianco D, Iwamoto M, Butterton JR, Yeh WW.
    J Clin Pharmacol; 2018 May 01; 58(5):666-673. PubMed ID: 29329497
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evidence of different pharmacokinetics between cyclosporine and tacrolimus in renal transplant recipients: why cyclosporine is monitored by C2 level and tacrolimus by trough level.
    Takeuchi H, Matsuno N, Hirano T, Toraishi T, Konno O, Nakamura Y, Iwamoto H, Hama K, Unezaki S, Nagao T.
    Transplant Proc; 2008 Sep 01; 40(7):2240-2. PubMed ID: 18790203
    [Abstract] [Full Text] [Related]

  • 20. FTY720 and cyclosporine: evaluation for a pharmacokinetic interaction.
    Kovarik JM, Schmouder RL, Barilla D, Büche M, Rouilly M, Berthier S, Wang Y, Van Saders C, Mayer T, Gottlieb AB.
    Ann Pharmacother; 2004 Sep 01; 38(7-8):1153-8. PubMed ID: 15138297
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.